Source: Health Canada shortage reports · Updated Aug 17, 2026
Some Venlafaxine products are in shortage in Canada (10 of 47 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Dec 31, 2026.
An antidepressant (SNRI) used to treat depression and anxiety disorders.
Products affected
10 / 47
In shortage since
Jul 26, 2022
Est. full return
Dec 31, 2026
Reports on file
172
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
TARO-VENLAFAXINE XR
75MG · CAPSULE (EXTENDED RELEASE) · SUN PHARMA CANADA INC
DIN 02380080 · since Apr 13, 2026, est. end Sep 11, 2026 · Disruption of the manufacture of the drug.
Active shortage
TARO-VENLAFAXINE XR
37.5MG · CAPSULE (EXTENDED RELEASE) · SUN PHARMA CANADA INC
DIN 02380072 · since May 19, 2026, est. end Oct 23, 2026 · Disruption of the manufacture of the drug.
DIN 02304325 · since Mar 10, 2026, est. end Aug 20, 2026 · Disruption of the manufacture of the drug.
Active shortage
MINT-VENLAFAXINE XR
37.5MG · CAPSULE (EXTENDED RELEASE) · MINT PHARMACEUTICALS INC
DIN 02522977 · since Feb 6, 2026, est. end Dec 31, 2026 · Requirements related to complying with good manufacturing practices.
Active shortage
MINT-VENLAFAXINE XR
75MG · CAPSULE (EXTENDED RELEASE) · MINT PHARMACEUTICALS INC
DIN 02522985 · since Feb 6, 2026, est. end Dec 31, 2026 · Requirements related to complying with good manufacturing practices.
Active shortage
MINT-VENLAFAXINE XR
150MG · CAPSULE (EXTENDED RELEASE) · MINT PHARMACEUTICALS INC
DIN 02522993 · since Feb 6, 2026, est. end Dec 31, 2026 · Requirements related to complying with good manufacturing practices.
Active shortage
APO-VENLAFAXINE XR
37.5MG · CAPSULE (EXTENDED RELEASE) · APOTEX INC
DIN 02331683 · since Jun 20, 2023, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-VENLAFAXINE XR
37.5MG · CAPSULE (EXTENDED RELEASE) · APOTEX INC
DIN 02331683 · since May 9, 2023, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-VENLAFAXINE XR
150MG · CAPSULE (EXTENDED RELEASE) · APOTEX INC
DIN 02331705 · since Jul 26, 2022, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-VENLAFAXINE XR
75MG · CAPSULE (EXTENDED RELEASE) · APOTEX INC
DIN 02331691 · since Apr 18, 2023, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-VENLAFAXINE XR
150MG · CAPSULE (EXTENDED RELEASE) · APOTEX INC
DIN 02331705 · since Dec 13, 2022, no end estimate · Disruption of the manufacture of the drug.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Venlafaxine is currently affected by 10 active shortage reports filed with Health Canada by SUN PHARMA CANADA INC, SANDOZ CANADA INCORPORATED, TEVA CANADA LIMITED, MINT PHARMACEUTICALS INC and 1 others.
The reported causes are: disruption of the manufacture of the drug; demand increase for the drug; requirements related to complying with good manufacturing practices. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Venlafaxine is classified under “ANTIDEPRESSANTS” (ATC N06AX).
Recent changes
Aug 17, 2026
Estimated end date pushed back : Aug 21, 2026 → Sep 11, 2026
Aug 17, 2026
Estimated end date pushed back : Sep 18, 2026 → Oct 23, 2026
Aug 6, 2026
Status changed
Aug 3, 2026
New report filed
Jul 31, 2026
Estimated end date pushed back : Jun 20, 2026 → Aug 20, 2026
Jul 29, 2026
Shortage resolved
Jul 28, 2026
New report filed
Jul 28, 2026
New report filed
Jul 28, 2026
New report filed
Jul 15, 2026
New report filed
Jul 14, 2026
New report filed
Jul 14, 2026
Shortage resolved
Jul 14, 2026
Estimated end date pushed back : Jul 17, 2026 → Aug 21, 2026
Common questions
What is Venlafaxine used for?
An antidepressant (SNRI) used to treat depression and anxiety disorders.
When will Venlafaxine be back in stock in Canada?
The latest manufacturer estimate is Dec 31, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Venlafaxine in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.